Consensus Moderna, Inc.

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2025-06-20 EDT			5-day change	1st Jan Change
25.90 ^USD	+1.97%		-2.89%	-37.71%

06-18	Kennedy's new US vaccine panel to discuss measles shot for children	RE
06-18	Kennedy's new US vaccine panel to discuss measles shot for children	RE

Evolution of the Average Target: Moderna, Inc.

Evolution of the Target Price: Moderna, Inc.

Changes in Analyst Recommendations: Moderna, Inc.

aeb1d0b0dbe57661064d.80xLrRw0tbPXMVkm5NJnynmR-Vzq6Idl0uiixbyGC-w.nxs93iR-xvChWAAVprQBuTjOmguJkLYcn4LWtPPEaJu0ASzsdXLZ_LVoPg~633740effe27d01907b80a7d19088ef4

Analysts' recommendations: Moderna, Inc.

JPMorgan Adjusts Price Target on Moderna to $26 From $33, Maintains Underweight Rating	05-22	MT
Analyst recommendations: Target, Fastenal, Moderna, Snowflake, Ulta Beauty…	05-22
Deutsche Bank Adjusts Moderna Price Target to $28 From $35	05-14	MT
DBS Bank Adjusts Moderna Price Target to $25 From $35	05-13	MT
Redburn Atlantic Adjusts Moderna Price Target to $53 From $52, Maintains Neutral Rating	05-06	MT
Leerink Partners Adjusts Price Target on Moderna to $21 From $23	05-02	MT
Barclays Adjusts Price Target on Moderna to $40 From $45	05-02	MT
Morgan Stanley Adjusts Price Target on Moderna to $31 From $32	05-02	MT
UBS Adjusts Price Target on Moderna to $70 From $78, Maintains Buy Rating	05-02	MT
RBC Cuts Price Target on Moderna to $28 From $32, Keeps Sector Perform Rating	05-02	MT
Morgan Stanley Trims Price Target on Moderna to $31 From $32, Keeps Equalweight Rating	05-02	MT
RBC Cuts Price Target on Moderna to $28 From $32, Keeps Sector Perform Rating	05-01	MT
Citigroup Cuts Moderna Price Target to $32 From $40	05-01	MT
Bernstein Adjusts Moderna Price Target to $28 From $39, Maintains Market Perform Rating	04-28	MT
HSBC Adjusts Moderna Price Target to $49 From $58, Maintains Buy Rating	04-28	MT
TD Cowen Adjusts Moderna Price Target to $30 From $35, Maintains Hold Rating	04-23	MT
Wolfe Research Adjusts Moderna Price Target to $20 From $25, Keeps Underperform Rating	04-21	MT
Leerink Partners Adjusts Moderna Price Target to $23 From $27, Maintains Underperform Rating	04-16	MT
Goldman Sachs Adjusts Moderna's Price Target to $35 From $49, Keeps Neutral Rating	04-15	MT
Redburn Atlantic Adjusts Moderna's Price Target to $52 From $55, Keeps Neutral Rating	04-14	MT
Goldman Sachs Adjusts Price Target on Moderna to $35 From $49	04-14	MT
Morgan Stanley Adjusts Price Target on Moderna to $32 From $39, Keeps Equalweight Rating	04-09	MT
RBC Cuts Price Target on Moderna to $32 From $40, Keeps Sector Perform Rating	04-03	MT
JPMorgan Cuts Price Target on Moderna to $33 From $40, Maintains Underweight Rating	03-21	MT
Bernstein Adjusts Price Target on Moderna to $39 From $45, Keeps Market Perform Rating	03-18	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus (Composite)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Ecart obj. / dr
	MODERNA, INC.					+83.75%
	LONZA GROUP AG					+17.56%
	BEONE MEDICINES LTD.					+34.36%
	IQVIA HOLDINGS INC.					+22.91%
	CELLTRION, INC.					+32.39%
	EUROFINS SCIENTIFIC SE					-0.01%
	TEMPUS AI, INC.					-4.11%
	ICON PUBLIC LIMITED COMPANY					+20.74%
	ASCENDIS PHARMA A/S					+28.69%
	Average					+26.25%
	Weighted average by Cap.					+24.88%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

25.90USD

Average target price

47.59USD

Spread / Average Target

+83.75%

High Price Target

198.00USD

Spread / Highest target

+664.48%

Low Price Target

20.00USD

Spread / Lowest Target

-22.78%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

JPMorgan Chase
Deutsche Bank Securities
DBS Bank
Redburn Atlantic
RBC Capital Markets
UBS
Morgan Stanley
Barclays
Leerink Partners
Citigroup
Bernstein
HSBC
TD Cowen
Wolfe Research
Goldman Sachs
Berenberg Bank
BofA Securities
Evercore ISI
Argus
Baptista Research
Piper Sandler
BERENBERG	Harry Gillis
Jefferies & Co.
Brookline Capital Markets
Oppenheimer
Oddo BHF
JPMORGAN	Jessica Fye
RBC	Luca Issi
Redburn
Canaccord Genuity
William Blair & Co.
Guggenheim
SVB Securities LLC
Cowen
Chardan Research
SVB Leerink
Chardan
J.P. Morgan Chase